BALCAO · SERVICES-EDUCATIONAL SERVICES · SMALL CAP
Exousia Bio, Inc. LMMY
3 fiscal years on record · USD · FY2024 reported · SEC filings only
$51,395
In brief
What this company does
Written from the business description in Exousia Bio, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 17 October 2025. Every sentence was checked against that document before publication.
Growth
USD 3,750.00
Revenue, FY2024 · full 3-year series below
Revenue $
Net income $
FY2024 · Revenue 3750.0 · Net income 51395.0
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
1371 cents
of every revenue dollar became profit
Operating margin
Net margin
FY2024 · Operating 1370.5% · Net 1370.5%
ROE
Not applicable: equity was negative in this period, so return on equity has no meaning.
The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 |
| Operating income $B | 0.0 | −0.0 | −0.0 |
| EBITDA $B | 0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 |
| Net income $B | 0.0 | −0.0 | −0.0 |
| EPS, diluted $ | 0.00 | 0.00 | 0.00 |
| Dividend / sh $ | · | · | · |
| Payout % | · | · | · |
| ROE % | · | · | · |
| Shares out B | 0.01 | 0.01 | 0.01 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 12 reconciliationsAUDITED
Reconciled in 3 of 19 fiscal years. 83 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Educational Services
Listed onOTC market
Incorporated inWyoming
Fiscal year endsMay 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2022